1 Boil them for about 10 to 15 minutes. 2  As these potatoes do not have to be very soft like the mashed ones, you can test them with a fork after 10 minutes. 3  If they are not soft enough, boil them for 5 more minutes, and then test them.
Usually, this fee is $60 per month but the broker is now providing you with a chance to avoid paying this fee and register for a free-of-charge demo account for the platform. You can register here.
Being first to market gives Merck the chance to establish a foothold. Priced at $12,500 per month -- or about $150,000 per year -- Keytruda is obviously expensive.But it had unprecedented response rates in heavily pretreated patients for advanced melanoma, a disease that's particularly swift and deadly, so it should be adopted quickly.owever, determining whether it's Bristol-Myers Squibb 's (NYSE:BMY) Opdivo or Merck & Co. 's (NYSE:MRK) Keytruda that will capture the lion's share of the PD-1 market is uncertain. We asked our Motley Fool experts to weigh in with their thoughts on which of these drugs is likely to be more successful.